Search Results - "Damen, Ester"

P904: LOCOMMOTION: A PROSPECTIVE, OBSERVATIONAL, MULTINATIONAL STUDY OF REAL‐LIFE CURRENT STANDARDS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA– FINAL ANALYSIS AT 2‐YEAR FOLLOW‐UP by Moreau, Philippe, Weisel, Katja, De Stefano, Valerio, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad, Lindsey‐Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Vincent, Laure, Perrot, Aurore, Benjamin, Reuben, Donk, Niels W.C.J., Ocio, Enrique, In‘t Groen‐Damen, Ester, Roccia, Tito, Schecter, Jordan, Haddad, Imene, Strulev, Vadim, Mitchell, Lada, Buyze, Jozefien, Saarinen, Silva, Costa Filho, Octavio, Einsele, Hermann, Mateos, Maria‐Victoria

Get full text

The human Vps29 retromer component is a metallo-phosphoesterase for a cation-independent mannose 6-phosphate receptor substrate peptide by Damen, Ester, Krieger, Elmar, Nielsen, Jens E, Eygensteyn, Jelle, van Leeuwen, Jeroen E M

“…The retromer complex is involved in the retrograde transport of the CI-M6PR (cation-independent mannose 6-phosphate receptor) from endosomes to the Golgi. It…”
Get full text

Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study by Delforge, Michel, Moreau, Philippe, Einsele, Hermann, De Stefano, Valerio, Lindsey-Hill, Joanne, Vincent, Laure, Mangiacavalli, Silvia, Perrot, Aurore, Ocio, Enrique, ten Seldam, Silene, in ’t Groen-Damen, Ester, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan Mark, Roccia, Tito, Gries, Katharine S., Nesheiwat, Tonia, Wapenaar, Robert, Mateos, Maria-Victoria, Weisel, Katja

“…8030 Background: Evaluation of patient (pt)-reported outcomes provides insight into how real-life SOC treatments (tx) affect HRQoL for pts with RRMM…”
Get full text

Subgroup analyses in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study by Einsele, Hermann, Moreau, Philippe, De Stefano, Valerio, Dytfeld, Dominik, Angelucci, Emanuele, Benjamin, Reuben, Goldschmidt, Hartmut, van de Donk, Niels W.C.J., Besemer, Britta, Scheid, Christof, Vij, Ravi, in ’t Groen-Damen, Ester, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan Mark, Roccia, Tito, Nesheiwat, Tonia, Wapenaar, Robert, Weisel, Katja, Mateos, Maria-Victoria

“…8031 Background: Patients (pts) with RRMM who are triple-class exposed (proteasome inhibitor [PI], immunomodulatory drug [IMiD], and anti-CD38 monoclonal…”
Get full text

P-324 LocoMMotion: a prospective, observational, multinational study of real-life current standards of care in patients with relapsed/refractory multiple myeloma–final analysis at 2-year follow-up by Weisel, Katja, Moreau, Philippe, De Stefano, Valerio, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad, Lindsey-Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Vincent, Laure, Perrot, Aurore, Benjamin, Reuben, van de Donk, Niels, Ocio, Enrique, Groen-Damen, Ester in't, Roccia, Tito, Schecter, Jordan, Haddad, Imène, Strulev, Vadim, Mitchell, Lada, Buyze, Jozefien, Saarinen, Silva, Filho, Octavio Costa, Einsele, Hermann, Mateos, Maria-Victoria

Get full text

MM-464 LocoMMotion: A Prospective, Observational, Multinational Study of Real-Life Current Standards of Care in Patients With Relapsed/Refractory Multiple Myeloma – Final Analysis at 2-Year Follow-up by Moreau, Philippe, Weisel, Katja, de Stefano, Valerio, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad, Lindsey-Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Vincent, Laure, Perrot, Aurore, Benjamin, Reuben, van de Donk, Niels, Ocio, Enrique, Groen-Damen, Ester in ‘t, Roccia, Tito, Schecter, Jordan, Haddad, Imène, Strulev, Vadim, Mitchell, Lada, Buyze, Jozefien, Saarinen, Silva, Filho, Octavio Costa, Einsele, Hermann, Mateos, María-Victoria

“…LocoMMotion (NCT04035226), the first prospective observational study assessing the effectiveness and safety of real-life standard of care (SOC) treatments for…”
Get full text

POSTER: MM-464 LocoMMotion: A Prospective, Observational, Multinational Study of Real-Life Current Standards of Care in Patients With Relapsed/Refractory Multiple Myeloma – Final Analysis at 2-Year Follow-Up by Moreau, Philippe, Weisel, Katja, de Stefano, Valerio, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad, Lindsey-Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Vincent, Laure, Perrot, Aurore, Benjamin, Reuben, van de Donk, Niels, Ocio, Enrique, in ’t Groen-Damen, Ester, Roccia, Tito, Schecter, Jordan, Haddad, Imène, Strulev, Vadim, Mitchell, Lada, Buyze, Jozefien, Saarinen, Silva, Costa, Octavio, Einsele, Hermann, Mateos, María-Victoria

Get full text

P-243: Subgroup analyses from the LocoMMotion study of real-life current standard of care (SOC) in patients with relapsed/refractory multiple myeloma (RRMM) by Einsele, Hermann, Moreau, Philippe, De Stefano, Valerio, Dytfeld, Dominik, Angelucci, Emanuele, Benjamin, Reuben, Goldschmidt, Hartmut, van de Donk, Niels W.C.J., Besemer, Britta, Scheid, Christof, Vij, Ravi, Groen-Damen, Ester in ’t, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan, Roccia, Tito, Nesheiwat, Tonia, Wapenaar, Robert, Weisel, Katja, Mateos, María-Victoria

Get full text

P-239: Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life standard of care (SOC) treatments: results from the LocoMMotion study by Delforge, Michel, Moreau, Philippe, Einsele, Hermann, De Stefano, Valerio, Lindsey-Hill, Joanne, Vincent, Laure, Mangiacavalli, Silvia, Perrot, Aurore, Ocio, Enrique, ten Seldam, Silene, Groen-Damen, Ester in ’t, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan, Roccia, Tito, Gries, Katharine, Nesheiwat, Tonia, Wapenaar, Robert, Mateos, María-Victoria, Weisel, Katja

Get full text

P-264: Updated results from LocoMMotion: A prospective, noninterventional, multinational study of real-life current standards-of-care in heavily pretreated patients with relapsed/refractory multiple myeloma by Moreau, Philippe, Weisel, Katja, De Stefano, Valerio, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad, Lindsey-Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Vincent, Laure, Perrot, Aurore, Benjamin, Reuben, van de Donk, Niels W.C.J., Ocio, Enrique, Groen-Damen, Ester in ’t, Roccia, Tito, Schecter, Jordan, Semerjian, Maria, Haddad, Imène, Strulev, Vadim, Mitchell, Lada, Buyze, Jozefien, Nesheiwat, Tonia, Einsele, Hermann, Mateos, María-Victoria

Get full text

ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site by Jansen, Suzanne M., Sleumer, Laura S., Damen, Ester, Meijer, Inez M.J., van Zoelen, Everardus J.J., van Leeuwen, Jeroen E.M.

“…Poor downregulation of ErbB receptors is associated with enhanced downstream signaling and tumorigenesis. It has been suggested that poor downregulation of…”
Get full text